Form 4 holding
Chief Medical Officer
HilleVax, Inc.
- Security class
- Common Stock
- Shares / value
- 214,892
- Estimated value
- $3,208,660
- Report date
- 08 Feb 2024
- Price
- $14.93
- Ownership
- Direct
Astrid Borkowski
Insider Reports History
- Reporting-owner location
- Boston, MA
- Latest reporting-owner signature
-
/s/ Paul Bavier, Attorney-in-Fact for Astrid Borkowski
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Astrid Borkowski
Form 4 holding
Chief Medical Officer
HilleVax, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 69,852
- Estimated value
- Report date
- 08 Feb 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Astrid Borkowski
4
HLVX
HilleVax, Inc.
- Report period
- 08 Feb 2024
- Transactions
- 3
- Transaction value
- -$58,726
- Accepted by SEC
- 12 Feb 2024, 19:35
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
HLVX
HilleVax, Inc.
- Report period
- 15 Dec 2023
- Transactions
- 1
- Transaction value
- -$155,000
- Accepted by SEC
- 18 Dec 2023, 17:34
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
HLVX
HilleVax, Inc.
- Report period
- 01 Dec 2023
- Transactions
- 2
- Transaction value
- -$287,000
- Accepted by SEC
- 05 Dec 2023, 16:52
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
HLVX
HilleVax, Inc.
- Report period
- 17 Nov 2023
- Transactions
- 1
- Transaction value
- -$140,000
- Accepted by SEC
- 20 Nov 2023, 16:53
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
HLVX
HilleVax, Inc.
- Report period
- 08 Nov 2023
- Transactions
- 1
- Transaction value
- -$65,000
- Accepted by SEC
- 13 Nov 2023, 17:25
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
HLVX
HilleVax, Inc.
- Report period
- 21 Jun 2023
- Transactions
- 1
- Transaction value
- -$161,100
- Accepted by SEC
- 23 Jun 2023, 10:09
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
HLVX
HilleVax, Inc.
- Report period
- 01 Feb 2023
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 03 Feb 2023, 15:22
- Role
- Chief Medical Officer
- Next action
- Open filing details
3
HLVX
HilleVax, Inc.
- Report period
- 28 Apr 2022
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 28 Apr 2022, 21:45
- Role
- Chief Medical Officer
- Next action
- Open filing details